Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients

Blood

Volumn 89, Issue 7, 1997, Pages 2472-2479

  Kobayashi, Daisuke ^a   Watanabe, Naoki ^a,b   Yamauchi, Naofumi ^a   Tsuji, Naoki ^a   Sato, Tsutomu ^a   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DOXORUBICIN; MANGANESE SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESISTANCE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; PREDICTION; PRIORITY JOURNAL;

EID: 0030955037     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2472     Document Type: Article

References (43)

1. Bradley G, Juranka PF, Ling V: Mechanism of multidrug resistance. Biochim Biophys Acta 948:87, 1988
2. Krishan A, Sauerteig A, Wellham LL: Flow cytometric studies on modulation of cellular adriamycin retention by phenothiazines. Cancer Res 45:1046, 1985
3. Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ: Multifactorial resistance to adriamycin: Relationship of DNA repair, glutathione transferase activity drug efflux, and p-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res 48:3595, 1988
4. Fruehauf JP, Mimnaugh EG, Sinha BK: Doxorubicin-induced cross-resistance to tumor necrosis factor (TNF) related to differential TNF processing. J Immunother 10:165, 1991
5. Maeda M, Watanabe N, Okamoto T, Tsuji N, Niitsu Y: Endogenous tumor necrosis factor functions as a resistant factor against adriamycin. Int J Cancer 58:376, 1994
6. Niitsu Y, Watanabe N, Neda H, Yamauchi N, Maeda M, Sone H, Kuriyama H: Induction of synthesis of tumor necrosis factor in human and murine cell lines by exogenous recombinant human tumor necrosis factor. Cancer Res 48:5407, 1988
7. Himeno T, Watanabe N, Yamauchi N, Maeda M, Tsuji Y, Okamoto T, Neda H, Niitsu Y: Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res 50:4941, 1990
8. Okamoto T, Watanabe N, Yamauchi N, Tsuji Y, Tsuji N, Itoh Y, Neda H, Niitsu Y: Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor. Cancer Res 52:5278, 1992
9. Tsuji Y, Watanabe N, Okamoto T, Tsuji N, Sasaki H, Akiyama S, Yamauchi N, Niitsu Y: Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity. Cancer Res 52:6258, 1992
10. Yamauchi N, Kuriyama H, Watanabe N, Neda H, Maeda M, Niitsu Y: Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res 49:1671, 1989
11. Yamauchi N, Watanabe N, Kuriyama H, Neda H, Maeda M, Himeno T, Tsuji Y, Niitsu Y: Suppressive effects of intracellular glutathione on hydroxyl radical production induced by tumor necrosis factor. Int J Cancer 46:884, 1990
12. Himeno T, Watanabe N, Yamauchi N, Maeda M, Okamoto T, Tsuji N, Tsuji Y, Akiyama S, Sasaki H, Niitsu Y: Induction of synthesis of manganous superoxide dismutase in L-M(PNTNF) cells carrying an inducible TNF gene. Int J Cancer 50:1, 1992
13. Segel EK, Ellegaard J, Borregaard N: Development of the phagocytic and cidal capacity during maturation of myeloid cells: Studies on cells from patients with chronic myelogenous leukaemia. Br J Haematol 67:3, 1987
14. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65:55, 1983
15. Twentyman PR, Fox NE, Rees JKH: Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. Br J Haematol 71:19, 1989
16. Kaspers GJL, Pieters R, Zantwijk CH, Laat PAJM, Waal FC, Wering ER, Veerman AJP: In vitro drug sensitivity of nomal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. Br J Cancer 64:469, 1991
17. Pitzurra L, Blasi E, Bartoli A, Marconi P, Bistoni F: A rapid objective immunofluorescence microassay: Application for detection of surface and intracellular antigens. J Immunol Meth 135:71, 1990
18. Oberley LW, Spitz DR: Nitroblue tetrazolium. CRC Handbook of Methods for Oxyg Rad Res. Boca Raton, FL, 1985, p 217
19. Scheper RJ, Bulte JWM, Brakkee JGP, Quak JJ, Schoot E, Balm AJM, Meuer CJLM, Broxterman HJ, Kuiper CM, Lankelma J, Pinedo HM: Monoclonal antibody JSB-1 detects a highly conserved epitope on the p-glycoprotein associated with multi-drug-resistance. Int J Cancer 42:389, 1988
20. Goasguen JE, Dossot JM, Fardel O, Mee FL, Gall EL, Leblay R, LePrise PY, Chaperon J, Fauchet R: Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: Prognostic implications. Blood 81:2394, 1993
21. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM, Norris MD: Expression of the mulridrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 54:5036, 1994
22. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M: Lipofection: A highly efficient, lipid-mediated DNA-transffection procedure. Proc Natl Acad Sci USA 84:7413, 1987
23. Fukuda R, Satoh S, Nguyen XT, Uchida Y, Kohge N, Akagi S, Ikeda S, Watanabe M, Fukumoto S: Expression rate of cytokine mRNA in the liver of chronic hepatitis C: Comparison with chronic hepatitis B. J Gastroenterol 30:41, 1995
24. Dranoff G, Jaffee D, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539, 1993
25. Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 85:6460, 1988
26. Jaffee EM, Dranoff G, Cohen LK, Hauda KM, Clift S, Marshall FF, Mulligan RC, Pardoll DM: High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res 53:2221, 1993
27. Moritz T, Patel VP, Williams DA: Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vetors. J Clin Invest 93:1451, 1994
28. Hanenberg H, Xiao XL, Hashino K, Kato I, Williams DA: Mechanism of high efficiency supernatant-mediated gene transfer on recombinant fibronectin fragments. Exp Hematol 23:747, 1995
29. Meijer C, Mulder NH, Bosscha HT, Zijlstra JG, Vries EGE: Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line. Cancer Res 47:4613, 1987
30. Doroshow JH: Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc Natl Acad Sci USA 83:4514, 1986
31. Chao CCK, Huang YT, Chang MMA, Chou WY, Chao SL: Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line. Mol Pharmacol 41:69, 1991
32. Nakagawa K, Saijo N, Tsuchida S, Sasaki M, Tsunokawa Y, Yokota J, Muramatsu M, Sato K, Terada M, Tew KD: Glutathione S-transferase π as a determinant of drug resistance in transfectant cell lines. J Biol Chem 265:4296, 1990
33. Hao XY, Bergh J, Brodin O, Hellman U, Mannervik B: Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes. Carcinogenesis 15:1167, 1994
34. Tidefelt U, Rosenborg AE, Paul C, Hao XY, Mannervik B, Eriksson LC: Expression of glutathione transferase π as a predictor for treatment results at dirrerent stages of acute nonlymphoblastic leukemia. Cancer Res 52:3281, 1992
35. Hall A, Foster S, Proctor SJ, Cattan AR: Purification and characterization of a pi class glutathione S-transferase from human leukaemic cells. Br J Haematol 76:494, 1990
36. 6-alkylguanine-DNA-alkyltransferase and p-glycoprotein in adult patients with leukaemia. Br J Haematol 85:103, 1993
37. Slapak CA, Mizunuma N, Kufe DW: Expression of the multidrug resistance associated protein and p-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood 84:3113, 1994
38. Baer MR, Bloomfield CD: Multidrug resistance in acute myeloid leukemia. J Natl Cancer Invest 83:663, 1991
39. Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG: Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902, 1994
40. Zaman GJR, Flens MJ, Leusden MR, Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P: The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91:8822, 1994
41. Zyad A, Benard J, Tursz T, Clarke R, Chouaib S: Resistance to TNF-α and adriamycin in the human breast cancer MCF-7 cell line: Relationship to MDR1, MnSOD, and TNF gene expression. Cancer Res 54:825, 1994
42. Bann N, Takahashi Y, Takayama T, Kura T, Katahira T, Sakamaki S, Niitsu Y: Transfection of glutathione s-transferase (GST)-π antisense cDNA increases sensitivity of colon cancer cell line to adriamycin, cisplatin, melphalan and etoposide. Cancer Res 56:3577, 1996
43. Corrias MV, Tonini GP: An oligomer complementary to the 5′ end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells. Anticancer Res 12:1431, 1992